Dark Therapy - Clinical Pharmacology

Clinical Pharmacology

Researchers hypothesize that benefits of being in the dark are due to melatonin production by the pineal gland, which occurs when the eyes are deprived of light, as shown during controlled light-dark cycles, even for some blind subjects, indicating that melanopsin is responsible for circadian entrainment in humans.

Read more about this topic:  Dark Therapy